Sulfuric Acid

Sulfuric Acid

SCHEMBL2484445

O=S(=O)(O)O.OCCNc1ccccc1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
MAPT P10636 4/20 0.52
RECQL P46063 1/20 0.50
MCL1 Q07820 1/20 0.50
CA12 O43570 3/20 0.47
CA2 P00918 3/20 0.47
CA9 Q16790 3/20 0.47
RORC P51449 1/20 0.46
L3MBTL1 Q9Y468 3/20 0.45
KCNH3 Q9ULD8 2/20 0.45
KDM4E B2RXH2 5/20 0.44
GAA P10253 4/20 0.44
LMNA P02545 3/20 0.44
CYP3A4 P08684 1/20 0.44
BLM P54132 1/20 0.44
GFER P55789 1/20 0.44
PMP22 Q01453 1/20 0.44
CDC25A P30304 1/20 0.43
POLB P06746 2/20 0.43
MITF O75030 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL8441340 0.96 ALDH1A1 (0.48) ALDH1A1MAPTRECQLMCL1CA12
Sulfuric Acid SCHEMBL8501569 0.91 CA12 (0.44) ALDH1A1MAPTRECQLMCL1CA12
Sulfuric Acid SCHEMBL8441342 0.90 CA12 (0.52) ALDH1A1MAPTRECQLMCL1CA12
Sulfuric Acid SCHEMBL8501318 0.89 CA12 (0.47) ALDH1A1MAPTRECQLMCL1CA12
Sulfuric Acid SCHEMBL30019534 0.89 CA12 (0.43) ALDH1A1MAPTRECQLCA12CA2
SCHEMBL8115 0.89 ALDH1A1 (0.64) ALDH1A1MAPTRECQLMCL1L3MBTL1
Sulfuric Acid SCHEMBL1605645 0.88 MAPT (0.59) ALDH1A1MAPTCA12CA2CA9
Water SCHEMBL11613453 0.87 ALDH1A1 (0.61) ALDH1A1MAPTRECQLMCL1L3MBTL1
Hydrochloric Acid SCHEMBL1683326 0.87 ALDH1A1 (0.61) ALDH1A1MAPTRECQLMCL1L3MBTL1
Bromide SCHEMBL28400204 0.87 ALDH1A1 (0.61) ALDH1A1MAPTRECQLMCL1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1017358-B1 REDUCTION OF HAIR GROWTH GILLETTE CO (US) 2004-08-11 EP claimed
EP-1017358-A1 REDUCTION OF HAIR GROWTH THE GILLETTE COMPANY (US) 2000-07-12 EP claimed
US-5939458-A APPLYING AN INHIBITOR OF AMINOACYL-TRNA SYNTHETASE TO THE SKIN GILLETTE COMPANY, THE 1999-08-17 US claimed
WO-1999015136-A1 REDUCTION OF HAIR GROWTH THE GILLETTE COMPANY (US) 1999-04-01 WO claimed
CN-115368900-B BOE etching solution for semiconductor and preparation method thereof 昆山晶科微电子材料有限公司 2023-11-28 CN disclosed
EP-3212183-B1 SYNERGISTIC COMPOSITIONS FOR TREATING MICROBIAL INFECTIONS UNIV ROCHESTER (US) 2019-10-02 EP disclosed
US-10028931-B2 Synergistic compositions for treating microbial infections UNIVERSITY OF ROCHESTER (US) 2018-07-24 US disclosed
EP-3212183-A1 SYNERGISTIC COMPOSITIONS FOR TREATING MICROBIAL INFECTIONS University of Rochester (US) 2017-09-06 EP disclosed
US-20170246139-A1 SYNERGISTIC COMPOSITIONS FOR TREATING MICROBIAL INFECTIONS UNIVERSITY OF ROCHESTER (US) 2017-08-31 US disclosed
WO-2016070021-A1 SYNERGISTIC COMPOSITIONS FOR TREATING MICROBIAL INFECTIONS UNIVERSITY OF ROCHESTER (US) 2016-05-06 WO disclosed
US-8778631-B2 Mono charging system for selectively introducing non-native amino acids into proteins using an in vitro protein synthesis system SUTRO BIOPHARMA, INC. (US) 2014-07-15 US disclosed
EP-2376647-B1 MONO CHARGING SYSTEM FOR SELECTIVELY INTRODUCING NON-NATIVE AMINO ACIDS INTO PROTEINS USING AN IN VITRO PROTEIN SYNTHESIS SYSTEM SUTRO BIOPHARMA INC (US) 2014-03-05 EP disclosed
EP-0389817-A1 Silver halide color photographic materials MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1990-10-03 EP disclosed
EP-0330443-A2 Cyan dye-forming couplers and photographic materials containing same EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1989-08-30 EP disclosed
EP-0304001-A2 Coupler for photographic use KONICA CORPORATION (JP) 1989-02-22 EP disclosed
US-4774053-A MULTILAYER-VARIOUS SPEED SILVER HALIDE EMULSION KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1988-09-27 US disclosed
EP-0276046-A2 Light-sensitive silver halide color photographic material containing multi-functional dye KONICA CORPORATION (JP) 1988-07-27 EP disclosed
US-4499179-A ABRASION RESISTANCE PROTECTIVE COATINGS KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1985-02-12 US disclosed
US-4444872-A CYAN PHENOLIC COUPLER KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1984-04-24 US disclosed
US-4299914-A Method for forming a cyan dye image KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1981-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10028931-B2 Synergistic compositions for treating microbial infections RNASE1, RNASEL, RNASEH1 ALDH1A1 3822/4885MAPT 4406/4885RECQL 682/4885
US-20170246139-A1 SYNERGISTIC COMPOSITIONS FOR TREATING MICROBIAL INFECTIONS RNASE1, RNASEL, RNASEH1 ALDH1A1 3822/4885MAPT 4406/4885RECQL 682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.